Perception of Spanish professionals on therapeutic adherence of dual diagnosis patients.
暂无分享,去创建一个
J. Bobes | C. Roncero | M. Casas | A. Terán | N. Szerman | J. M. Vázquez | S. Gómez-Baeza
[1] J. M. Vázquez,et al. Percepción de los profesionales Españoles sobre la Adherencia Terapéutica en Patología Dual , 2013 .
[2] C. Roncero,et al. Risk factors for cocaine-induced psychosis in cocaine-dependent patients , 2011, European Psychiatry.
[3] P. Vega,et al. Cocaine abuse or dependency and other pyschiatric disorders. Madrid study on dual pathology. , 2013, Revista de psiquiatria y salud mental.
[4] G. Perugi,et al. Correlations Between Awareness of Illness (Insight) and History of Addiction in Heroin-Addicted Patients , 2012, Front. Psychiatry.
[5] José J Rodríguez-Solano,et al. Psychiatric disorders associated with alcoholism: 2 year follow-up of treatment. , 2012, Actas espanolas de psiquiatria.
[6] C. Roncero,et al. Treatment adherence to treatment in substance users referred from Psychiatric Emergency service to outpatient treatment. , 2012, Actas espanolas de psiquiatria.
[7] C. Roncero,et al. [Evaluation of sleep disorders in drug dependent inpatients]. , 2012, Medicina clinica.
[8] A. Douaihy,et al. Treatment of substance abusing patients with comorbid psychiatric disorders. , 2012, Addictive behaviors.
[9] C. Roncero,et al. Protocols of Dual Diagnosis Intervention in Schizophrenia , 2011 .
[10] M. Escamilla,et al. Substance use disorder and schizophrenia: prevalence and sociodemographic characteristics in the Latin American population. , 2011, Actas espanolas de psiquiatria.
[11] C. Roncero,et al. Therapeutic management and comorbidities in opiate-dependent patients undergoing a replacement therapy programme in Spain: the PROTEUS study , 2011 .
[12] D. Lacasta-Tintorer,et al. [Do depressed patients comply with treatments prescribed?: a cross-sectional study of adherence to the antidepressant treatment]. , 2011, Actas espanolas de psiquiatria.
[13] F. Arias Horcajadas,et al. [Pilot study on the prevalence of dual pathology in community mental health and substance misuse services in Madrid]. , 2011, Adicciones.
[14] C. Roncero,et al. [Epidemiological and diagnostic axis I gender differences in dual diagnosis patients]. , 2011, Adicciones.
[15] P. Weiden,et al. Assessment of Adherence Problems in Patients with Serious and Persistent Mental Illness: Recommendations from the Expert Consensus Guidelines , 2010, Journal of psychiatric practice.
[16] J. Lindenmayer,et al. Safety and tolerability of deltoid and gluteal injections of paliperidone palmitate in schizophrenia , 2009, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[17] E. Vieta,et al. [Efficacy and safety of long-acting injectable risperidone in maintenance phase of bipolar and schizoaffective disorder]. , 2009, Actas espanolas de psiquiatria.
[18] J. López Castro,et al. [Benzodiazepine use in a sample of patients on a treatment program with opiate derivatives (PTDO)]. , 2009, Adicciones.
[19] M. Roca,et al. [Use of antidepressant treatment. Patients' perception]. , 2009, Actas espanolas de psiquiatria.
[20] J. Martínez-Raga,et al. Bipolar disorder associated to substance use disorders (dual diagnosis). Systematic review of the scientific evidence and expert consensus. , 2008, Actas espanolas de psiquiatria.
[21] D. Karlovic,et al. Assessment of nurse attitudes on psychiatric patient compliance with pharmacotherapy. , 2008, Acta clinica Croatica.
[22] R. Baldessarini,et al. Factors associated with treatment nonadherence among US bipolar disorder patients , 2008, Human psychopharmacology.
[23] J. Hoenicka,et al. [Dual diagnosis in psychiatric inpatients: prevalence and general characteristics]. , 2008, Investigacion clinica.
[24] C. Grella,et al. Role of social support and self-efficacy in treatment outcomes among clients with co-occurring disorders. , 2007, Drug and alcohol dependence.
[25] R. Drake,et al. Schizophrenia and co-occurring substance use disorder. , 2007, The American journal of psychiatry.
[26] A. Gual. Dual diagnosis in Spain. , 2007, Drug and alcohol review.
[27] R. Drake,et al. Enhancing validity in co-occurring disorders treatment research. , 2005, Schizophrenia bulletin.
[28] Alan I Green,et al. Improving the Care of Individuals with Schizophrenia and Substance Use Disorders: Consensus Recommendations , 2005, Journal of psychiatric practice.
[29] D. Kavanagh,et al. Integrated versus non-integrated management and care for clients with co-occurring mental health and substance use disorders: a qualitative systematic review of randomised controlled trials. , 2005, Social science & medicine.
[30] J. Alvidrez,et al. Comparisons of patients with comorbid psychiatric and substance use disorders: implications for treatment and service delivery. , 2004, The American journal of psychiatry.
[31] R. Drake,et al. Benzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disorders. , 2003, Psychiatric services.
[32] T. Fong,et al. Dual diagnosis and treatment compliance. , 2003, Psychiatric services.
[33] M. Casas,et al. Patología psiquiátrica asociada al alcoholismo , 2002 .
[34] S. Santamarina,et al. Esquizofrenia y sustancias psicotropas de consumo frecuente en nuestro medio , 2001 .
[35] L. Domínguez. Uso de neurolépticos atípicos en esquizofrénicos consumidores de cannabis , 2001 .
[36] K. Carey,et al. Treating substance abuse in the context of severe and persistent mental illness: clinicians' perspectives. , 2000, Journal of substance abuse treatment.
[37] A. Bellack,et al. Substance abuse treatment for people with schizophrenia. , 1998, Addictive behaviors.
[38] R. Kessler,et al. Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. , 1997, Archives of general psychiatry.